Analysis of vitamin D3 metabolites in survivors of infantile idiopathic hypercalcemia caused by CYP24A1 mutation or SLC34A1 mutation
Ewa Kowalska(Children's Memorial Health Institute), Mieczysław Litwin(Children's Memorial Health Institute), Ewa Pronicka(Children's Memorial Health Institute), Paulina Halat(Children's Memorial Health Institute), Janusz Książyk(Children's Memorial Health Institute), Elżbieta Ciara(Children's Memorial Health Institute), Agnieszka Janiec(Children's Memorial Health Institute), Rafał Rola(Children's Memorial Health Institute), Natalia Łaszcz(Children's Memorial Health Institute), Paweł Płudowski(Children's Memorial Health Institute), Marek Wójcik(Children's Memorial Health Institute), Aldona Wierzbicka(Children's Memorial Health Institute), Łukasz Obrycki(Children's Memorial Health Institute)
The Journal of Steroid Biochemistry and Molecular Biology
January 28, 2021
Cited by 3
Related Papers
2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents
|Journal of Hypertension|2016|1.4k
A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets
|Nature Genetics|1995|1.1k
Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia
|Journal of the American Society of Nephrology|2015|284
New perspective in diagnostics of mitochondrial disorders: two years’ experience with whole-exome sequencing at a national paediatric centre
|Journal of Translational Medicine|2016|233
Clinical implementation of RNA sequencing for Mendelian disease diagnostics
|Genome Medicine|2022|215